Contract facts
UnrestrictedNo full NAICS 621511 intel page yet. Browse NAICS intelligence
GENETIC NEWBORN SCREENING (OPTION YEAR 2) POP 01 OCT 2023 TO 30 SEP 2024, WACH, FT. IRWIN, CA is a federal Unrestricted award for W40m Usa Hca held by Perkinelmer Genetics, Inc. Estimated value $166K ($96K obligated). Current period of performance ends Sep 30, 2026. Last award drew 2 bidders. Place of performance: FORT IRWIN CA. Related solicitation W81K0021Q0242.
GENETIC NEWBORN SCREENING (OPTION YEAR 2) POP 01 OCT 2023 TO 30 SEP 2024, WACH, FT. IRWIN, CA
Recompete timing
PublicCurrent PoP ends Sep 30, 2026 (3 days remaining). Agencies typically plan 12–18 months ahead — at 0.1 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on W81K0021P0253? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordPerkinelmer Genetics, Inc — $773K obligated across 13 awards (firm-wide, all agencies).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W81K0021P0253?
W81K0021P0253 (Genetic newborn screening (option YEAR 2)) is a W40m Usa Hca award with a potential value of $166K, currently held by Perkinelmer Genetics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is W81K00-21-P-0253?
W81K00-21-P-0253 is the dashed form of PIID W81K0021P0253 (Genetic newborn screening (option YEAR 2)), held by Perkinelmer Genetics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded W81K0021P0253?
W40m Usa Hca awarded W81K0021P0253 to Perkinelmer Genetics, Inc (potential $166K).
Who is the incumbent on W81K0021P0253?
Perkinelmer Genetics, Inc is the incumbent with $773K across 13 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.
When does Perkinelmer Genetics, Inc’s W81K0021P0253 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on W81K0021P0253? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.